Wanwan Yi
Impact in
- Rehabilitation top 5%
- Wound Healing and Treatments
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications
- Silk-based biomaterials and applications
Papers in
- Oncology 4
- Peptidase Inhibition and Analysis 3
- Co-authors
- Hengwei Fan (6 shared papers)Shige Wang (2 shared papers)Hang Wu (1 shared paper)Jiulong Zhao (1 shared paper)Yu Zhang (1 shared paper)Ting Wang (1 shared paper)Hengwei Fan (7 shared papers)Zheng Chen (1 shared paper)
In The Last Decade
Wanwan Yi
20 papers receiving 273 citations
Peers
Comparison fields: 5 of 74
- Rehabilitation 86
- Biomaterials 92
- Molecular Medicine 34
- Urology 20
- Hematology 28
Countries citing papers authored by Wanwan Yi
This map shows the geographic impact of Wanwan Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanwan Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanwan Yi more than expected).
Fields of papers citing papers by Wanwan Yi
This network shows the impact of papers produced by Wanwan Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanwan Yi. The network helps show where Wanwan Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanwan Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 120 | |
| 2 | 2023 | 55 | |
| 3 | 2022 | 15 | |
| 4 | 2023 | 13 | |
| 5 | 2025 | 10 | |
| 6 | 2019 | 8 | |
| 7 | 2017 | 7 | |
| 8 | 2022 | 7 | |
| 9 | 2020 | 7 | |
| 10 | 2017 | 7 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 3 | |
| 14 | 2020 | 3 | |
| 15 | 2019 | 3 | |
| 16 | Employment Intention of Chinese Medical Students During the COVID-19 Epidemic: A Cross-Sectional Survey. | 2023 | 3 |
| 17 | 2020 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2023 | 1 |
About Wanwan Yi
Wanwan Yi is a scholar working on Molecular Biology, Oncology, Cancer Research, Infectious Diseases and Surgery, having authored 22 papers that have together received 276 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Peptidase Inhibition and Analysis (3 papers), Long-Term Effects of COVID-19 (2 papers), Ferroptosis and cancer prognosis (2 papers), Electrospun Nanofibers in Biomedical Applications (2 papers), SARS-CoV-2 detection and testing (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Rehabilitation (86 citations), Biomaterials (92 citations), Molecular Medicine (34 citations), Urology (20 citations) and Hematology (28 citations). Wanwan Yi has collaborated with scholars based in China, Cuba and Hong Kong. Frequent co-authors include Hengwei Fan, Shige Wang, Hang Wu, Jiulong Zhao, Yu Zhang, Ting Wang, Hengwei Fan, Zheng Chen, Lissette Agüero and Dionisio Zaldívar. Their work appears in journals such as Technology in Cancer Research & Treatment, Gene, International Journal of Biological Macromolecules, Human Cell and BMC Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.